Antitumor efficacy of AAV-mediated systemic delivery of interferon-β
Open Access
- 29 July 2005
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 13 (1) , 99-106
- https://doi.org/10.1038/sj.cgt.7700878
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- lnterferon‐β gene therapy for cancer: Basic research to clinical applicationCancer Science, 2004
- Restriction of neuroblastoma angiogenesis and growth by interferon-α/βSurgery, 2004
- Interferon-β gene therapy improves survival in an immunocompetent mouse model of carcinomatosisSurgery, 2004
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaquesBlood, 2002
- How does interferon work? Does it even matter?Cancer, 2002
- Human and Mouse IFN-β Gene Therapy Exhibits Different Anti-tumor Mechanisms in Mouse ModelsMolecular Therapy, 2001
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Interferon-β in Healthy Male VolunteersJournal of Interferon & Cytokine Research, 1996
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainNature Genetics, 1994
- Microvascular Injury in Pathogenesis of Interferon-Induced Necrosis of Subcutaneous Tumors in MiceJNCI Journal of the National Cancer Institute, 1989